;

Doing Business in APAC

APAC's rapidly evolving patchwork of rules governing AI in health care

China: Persistent compliance risks for CROs in clinical trials amid strengthened NMPA oversight

China's digital therapeutics and AI in health care: Where does regulation begin?

HGR compliance in practice: How foreign companies can lawfully conduct joint R&D in China without breaching genetic data rules

Strategic localization: Navigating China's new medical device registration framework

China takes a major step toward pharmaceutical trial data protection

Resolving life sciences disputes in China: Navigating 2025 Arbitration Law reform

Japan increasing promotion of clinical development, partnerships

Inventorship, de facto patent linkage, AI, and FRAND: IP strategy paramount in Japan